New weight loss pill MWN109 enters first human safety trial

NCT ID NCT06938269

Recruiting now Symptom relief Sponsor: Shanghai Minwei Biotechnology Co., Ltd Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage study tests a new tablet called MWN109 in healthy adults who are overweight or have obesity. The main goal is to check if the drug is safe and how the body processes it. About 60 participants will receive either the drug or a placebo, and researchers will monitor side effects and lab results. This is a first step to see if the drug might help with weight management in the future.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OVERWEIGHT OR OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder Overweight

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OVERWEIGHT OR OBESITY

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

CMAX Clinical Research
RECRUITING

Adelaide, South Australia, 5000, Australia

Contact Phone: •••-•••-•••• Email: •••••@•••••
Veritus Research
NOT_YET_RECRUITING

Bayswater, Victoria, 3153, Australia

Contact Phone: •••-•••-•••• Email: •••••@•••••